 |
Hedge Fund and Institutional NewsAnalysis of the equity holdings of hedge funds, mutual funds, and other institutions, including notable investors like Warren Buffett, John Paulson, and Bill Gates. Icahn Needs To Ante Up More If He Really Wants Clorox (CLX, BIIB, HAIN, LGF, MMI, TTWO, PG, CL, AMLN, FDML, IEP)by Todd Shriber | July 29th
Shares of consumer products giant Clorox (CLX), the maker of its namesake bleach and Hidden Valley salad dressings, are fractionally lower today despite a Bloomberg News report that says corporate raider Carl Icahn may have to pony up another $600 million if…  This Week in Billionaires: Soros Says Goodbye, Paulson Admits Mistake (BAC, C, WFC, AAPL, DNDN, MON)by Eric Monte | July 28th
Chastened by the declines in some financial services stocks, hedge fund legend John Paulson told investors last Thursday that he was “too aggressive” with some of his bets on the sector in his flagship funds and that he was reducing… Soros Calls It A Day, Will Return Money To Investors (AAPL, C, DHR, WFC, WFT, EM, MON, TEVA)by Todd Shriber | July 26th
Legendary investor George Soros is hanging up his hedge fund spikes, ending an illustrious career that has lasted over four decades. Soros’ $25.5 billion firm will return less than $1 billion to outside investors by the end of this year… Paulson Scales Back On Financials (BAC, C, COF, HIG, WFC, SNOFF, ANR, APC, LZ, RIG)by Todd Shriber | July 22nd
Chastened by the declines in some financial services stocks, hedge fund legend John Paulson told investors on Thursday that he was “too aggressive” with some of his bets on the sector in his flagship funds and that he was reducing… This Week in Billionaires: Icahn Makes an Offer, Sprott is Going Global (CLX, BIIB, DYN, MMI, DIS, MSFT, XOM, TEVA, MON, CVS, GE, PG, WMT, AG, AUY, SLW)by Eric Monte | July 21st
Shares of Clorox (CLX) traded higher this week after billionaire investor Carl Icahn offered to acquire the consumer products giant for $10.2 billion. Icahn’s offer valued California-based Clorox at $76.50 a share, or a 12% premium to where the stock closed… Sprott Looks Globally In Search Of New Opportunities (PHYS, ABX, EGO, IAG, SLW, XG, AG, AUY, MVG, XRA)by Todd Shriber | July 21st
Noted gold and silver bull Eric Sprott has made plenty of winning bets on junior mining and resource companies, many of them based in his firm’s home country of Canada. The Canadian market has proven rewarding for Sprott in terms… Buffett Ready To Bid Debt Ceiling Adieu (AXP, GE, KFT, KO, JNJ, COP, COST, UPS, USB)by Jason Smith | July 19th
Legendary investor Warren Buffett said the U.S. should do away with the debt ceiling, the issue that has recently roiled global equity markets as speculation has intensified that if Congress does not raise the debt ceiling, the “AAA” credit rating… Soros Fund Maintains Big Cash Position As Markets Remain Choppy (AAPL, C, EM, TEVA, WFT, CVS, DHR, MON, WFC)by Todd Shriber | July 19th
The $25.5 billion Quantum Endowment Fund is taking a step back from risk, paring the number of trades it commits to and is now about 75% in cash as it waits for better opportunities to come along, Bloomberg News reported, citing… Bridgewater’s Culture, Performance Not Typical Among Hedge Funds (GE, DIS, EEM, IVV, LQD, VWO, MSFT, ORCL, XOM)by Eric Monte | July 18th
Bridgewater Associates, the world’s largest hedge fund, may be home to one of the most unusual cultures in the hedge fund universe, but that doesn’t stop the firm from consistently trouncing its rivals. Last year, Bridgewater’s flagship fund, Pure Alpha,… Clorox Cleans Up As Icahn Offers $10.2B For The Company (CLX, AMLN, BIIB, MMI, REGN, CL, KMB, PG)by Todd Shriber | July 15th
Shares of Clorox (CLX), the maker of its namesake bleach and the Hidden Valley salad dressing brand, are soaring 7% after billionaire investor Carl Icahn offered to acquire the consumer products giant for $10.2 billion. Icahn’s offer values California-based Clorox at…  |
|
Follow us on
  |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |